Powered by OpenAIRE graph
Found an issue? Give us feedback


Metabolites as immunomodulatory additives for biomaterials
Funder: European CommissionProject code: 898858 Call for proposal: H2020-MSCA-IF-2019
Funded under: H2020 | MSCA-IF-EF-ST Overall Budget: 152,202 EURFunder Contribution: 152,202 EUR
OpenAIRE UsageCountsViews provided by UsageCounts
OpenAIRE UsageCountsDownloads provided by UsageCounts

The biomaterials are crucial for the surgical remediation of bone defects caused by various diseases e.g. osteoporosis and traumatic fractures. However, there are several risks associated with this treatment; first, the surgical procedure itself carries a potential risk of inflammation and bone infection, second, the bone replacement can fail requiring revision surgery. In fact, the host immune response to implanted materials and devices is the main factor that will determine a long-term functional outcome of the biomaterial mediated treatment. Therefore, the bone biomaterial ability to modulate the local immune environment for favorable treatment outcomes has to be considered. The usage of bioactive metabolites has emerged as one of the most novel and potent approach for immune response modulation. The incorporation of metabolites with immune regulatory properties seems an especially attractive option for biomaterials as it would ensure site-specific delivery system and allow modulation of the microenvironment. The goal of this project is to develop novel biomaterials with incorporated metabolites as a potentially effective and safe strategy to modulate local immune response towards favorable outcomes of surgical bone remediation. To achieve it, the recent concept of metabolomics with the state of the art biomaterial design and research will be combined in this project. This proposal includes the transfer of knowledge to the host institution and the training of the researcher in new techniques and skills. The multidisciplinary nature of the project is strong, combining materials science, biochemistry, and molecular biology. Results have the potential to pave the way for novel biomaterials significantly improving clinical outcomes for patients suffering from bone injuries.

Data Management Plans
  • OpenAIRE UsageCounts
    Usage byUsageCounts
    visibility views 83
    download downloads 86
  • 83
    Powered byOpenAIRE UsageCounts
Powered by OpenAIRE graph
Found an issue? Give us feedback

Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.

All Research products
<script type="text/javascript">
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=corda__h2020::378bbd4210f5251a89e2315995599df1&type=result"></script>');
For further information contact us at helpdesk@openaire.eu

No option selected